Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

United States Endoscopic Retrograde Cholangiopancreatography Devices Market Report 2016/2017 - Research and Markets

DUBLIN, November 4, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "US Market Report for Endoscopic Retrograde Cholangiopancreatography Devices 2017 - MedCore" report to their offering.

The value of the total U.S. market for ERCP devices increased in 2016. Growth is expected to persist throughout the forecasted period and will be driven by increases in unit sales complimented by a stable ASP. The vast majority of units in this market are sold to hospitals, with only relatively few units used in the outpatient centers. The six out of seven segments in this market exhibit positive unit sales trend, with only cannula segment losing unit sales level each year.

The U.S. market for ERCP defined in this report as sphincterotomes, biliary stone removal balloons, biliary stone removal baskets, biliary and pancreatic stents, biliary dilation balloons, biliary lithotripters, ERCP guidewires and ERCP cannulas. One of the largest segments in the total ERCP market was the ERCP guidewire segment. This segment represented approximately 25.5% of the total market in 2016.

The relatively large size of this segment is mainly due to this device being involved in most of the ERCP procedures as well as the fact that sometimes several units of this device are used within one ERCP procedure. All the devices discussed in this report are single-use and therefore correspond one-to-one with the underlying procedure, such as, for example, one stone-removal balloon device is used for one stone-removal procedure.

The major contributors to the unit growth in this market are ERCP guidewires and sphincterotomes due to the high volume and strong growth profiles of these products. This is a mature market which grows in-line with macro factors such as elderly population. One extra factor contributing to the growth is expanding therapeutical capability of the devices. In general, the pricing is stable in all of the segments.

Key Topics Covered:

1. Executive Summary

U.S. Gastrointestinal Endoscopic Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Procedure Codes Investigated

Markets Included

2. Disease Overview

2.1 Basic Anatomy

2.2 Gastrointestinal Disease: Treatment And Diagnostics

2.3 Patient Demographics

3. Product Assessment

3.1 Product Portfolios

3.2 Regulatory Issues And Recalls

3.3 Clinical Trials

3.4 Product Pipelines

4. Endoscopic Retrograde Cholangiopancreatography Device Market

4.1 Market Overview

4.2 Market Analysis And Forecast

4.3 Drivers And Limiters

4.4 Competitive Market Share Analysis

Companies Mentioned

  • Boston Scientific
  • Olympus
  • Medtronic
  • Cook Medical
  • Halyard
  • Medline
  • Pentax
  • ConMed
  • Fujinon
  • Moog
  • C. R. Bard
  • Endogastric
  • GE Healthcare

For more information about this report visit http://www.researchandmarkets.com/research/2qszw2/us_market_report

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.